Graham Cooper
Presidente en KEZAR LIFE SCIENCES, INC. .
Fortuna: - $ al 31/05/2024
Origen de la red de primer grado Graham Cooper.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Deutsche Bank Securities, Inc.
Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Deutsche Bank Securities, Inc. (DBSI) is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1971 and is a wholly-owned investment banking and brokerage arm of DB U.S. Financial Markets Holding Corp., ultimately held by Deutsche Bank AG (NYSE: DB, FRA: DBK) in Germany. DBSI provides securities brokerage and investment advisory services to domestic and international private clients and institutions. They are also a primary dealer in US government securities as designated by the Federal Reserve.
521
| Subsidiary | Investment Banks/Brokers | 521 |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY.
191
| Subsidiary | Miscellaneous Commercial Services | 191 |
Public Company | Biotechnology | 25 | |
Subsidiary | Pharmaceuticals: Major | 24 | |
Public Company | Biotechnology | 23 | |
20
| Subsidiary | Pharmaceuticals: Major | 20 |
Public Company | Biotechnology | 19 | |
Celladon Corp.
Celladon Corp. BiotechnologyHealth Technology Celladon Corp. is a clinical-stage biotechnology company, engaging in the development of cardiovascular gene therapy. The company's therapeutic portfolio for diseases characterized by SERCA enzyme deficiency includes both gene therapies and small molecule compounds. Its most advanced product candidate MYDICAR uses gene therapy to target SERCA2a, an enzyme that is deficient in heart failure patients. Celladon was founded by Roger J. Hajjar and Kenneth R. Chien on December 21, 2000 and is headquartered in San Diego, CA.
13
| Extinct | Biotechnology | 13 |
Public Company | Biotechnology | 13 | |
Public Company | Biotechnology | 8 | |
Public Company | Pharmaceuticals: Major | 3 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Graham Cooper a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Comptroller/Controller/Auditor Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Doctorate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree | |
University of Michigan | College/University | Masters Business Admin Undergraduate Degree Chairman Doctorate Degree Doctorate Degree Undergraduate Degree | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
University of California, Berkeley | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Founder Private Equity Investor Private Equity Analyst Private Equity Investor Private Equity Investor | |
Yale University | College/University | Undergraduate Degree Director/Board Member Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
University of California, Davis | College/University | Doctorate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Stanford University | College/University | Graduate Degree Masters Business Admin Doctorate Degree Undergraduate Degree | |
University of California San Diego | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree Corporate Officer/Principal | |
GOSSAMER BIO, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Treasurer | |
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Administrative Officer Corporate Officer/Principal | |
DENALI THERAPEUTICS INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
Orbital Therapeutics, Inc.
Orbital Therapeutics, Inc. BiotechnologyHealth Technology Orbital Therapeutics, Inc. is a company based in Cambridge, MA that aims to enhance health by utilizing RNA-based medicines to treat human diseases in innovative ways. The company is building a platform that combines RNA technology delivery methods, data science, and automation to develop a portfolio of medicines focused on vaccines, immunomodulation, protein replacement, and regenerative medicine. The company was founded by Drew Weissman, John M. Maraganore, Kristina M. Burow, Ravindra Majeti, Giuseppe Ciaramella, Eugene W. Yeo, Howard Y. Chang, and Carol Suh, with Giuseppe Ciaramella serving as the CEO since incorporation. | Biotechnology | Founder Founder Director/Board Member Founder | |
AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
SANA BIOTECHNOLOGY, INC. | Biotechnology | Founder Director/Board Member Director/Board Member | |
NEUMORA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member | |
AURINIA PHARMACEUTICALS INC. | Biotechnology | Director/Board Member Director/Board Member Investor Relations Contact | |
Ren Pharmaceuticals, Inc.
Ren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ren Pharmaceuticals was formed in the fall of 2006 with the aim of bringing together talented and experienced people who are passionate about building a cardio-renal/renal- focused drug development company. Ren Pharmaceuticals closed a Series A financing in November 2006 with Sanderling Ventures, Venrock Associates and Amgen Ventures as investors. The company's R&D is currently located in South San Francisco, California. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
JPMorgan Securities LLC
JPMorgan Securities LLC Investment ManagersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Investment Managers | Analyst-Equity Analyst-Equity Corporate Officer/Principal | |
CELGENE | Biotechnology | Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
FATE THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member Chief Executive Officer | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO | |
SIENNA BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO | |
ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
National Venture Capital Association
National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Director/Board Member | |
PRIME MEDICINE, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
REGULUS THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Investor Relations Contact | |
BLUEPRINT MEDICINES CORPORATION | Biotechnology | Director/Board Member General Counsel Human Resources Officer | |
Semma Therapeutics, Inc.
Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member Chairman | |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal General Counsel | |
Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
LYELL IMMUNOPHARMA, INC. | Biotechnology | General Counsel Director/Board Member Chief Tech/Sci/R&D Officer | |
Aerium Therapeutics, Inc.
Aerium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aerium Therapeutics, Inc. is an American biotechnology company that focuses on epidemic and pandemic preparedness. The company is based in Lausanne and has operations in the United States. The company's mission is to discover and develop antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic and pandemic threats. Aerium Therapeutics has a team of world-class scientists and biotechnology veterans, as well as experienced investors. Aerium's lead assets are monoclonal antibodies that show broad activity against important variants of concern (VOCs) of SARS-CoV-2, including Omicron and its subvariants. The company plans to expand its pipeline to antiviral therapeutics in late 2022 and will broaden its focus to other epidemic and pandemic threats in the future. The CEO of the company is Rajeev Venkayya. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Public Communications Contact | |
SYROS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Founder Director/Board Member |
Estadísticas
Internacional
Estados Unidos | 50 |
Canadá | 2 |
Sectorial
Health Technology | 32 |
Consumer Services | 12 |
Finance | 5 |
Commercial Services | 4 |
Health Services | 2 |
Operativa
Director/Board Member | 678 |
Corporate Officer/Principal | 274 |
Independent Dir/Board Member | 188 |
Chief Executive Officer | 96 |
Chairman | 94 |
Las relaciones más conectadas
Insiders | |
---|---|
Robert Nelsen | 80 |
Amir Nashat | 51 |
Douglas Cole | 44 |
Kristina Burow | 43 |
Franklin Berger | 41 |
Stephen Knight | 39 |
Todd Foley | 38 |
John Maraganore | 38 |
Barbara Dalton | 35 |
Dan Omstead | 33 |
Larry Marcus | 33 |
Paul Berns | 28 |
Kathleen Walsh | 27 |
Faheem Hasnain | 27 |
Wendy Dixon | 25 |
- Bolsa de valores
- Insiders
- Graham Cooper
- Conexiones Empresas